Navigation Links
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea

18, a topical compound based on the SansRosa technology, for the treatment of redness associated with rosacea and other skin disorders.

Research has shown that compounds can be created by chemically modifying certain tetracyclines and that these new compounds have properties that may make them effective in treating diseases involving inflammation and/or destruction of the body's connective tissues. CollaGenex is evaluating various chemically modified tetracyclines (so called "IMPACS" compounds because they are Inhibitors of Multiple Proteases And CytokineS") to assess whether they are safe and effective in these applications. The Company has a pipeline of innovative product candidates with possible applications in dermatology and other disease states. In addition, CollaGenex has acquired the SansRosa(TM) technology, which consists of a class of compounds that have shown promise in reducing the redness associated with rosacea, and the Restoraderm(R) technology, a unique, proprietary dermal drug delivery system. CollaGenex plans to leverage these platforms to develop a range of topical dermatological products with enhanced pharmacologic and cosmetic properties.

To receive additional information on the Company, please visit our Web site at www.collagenex.com, which does not form part of this press release.

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to the Company's plans, timing and success related to its patent applications and the launch of Oracea for the treatment of inflammatory lesions of rosacea, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. CollaGenex' actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including those factors contained in the most recent Form 10-K for the yea
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
5. New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting
6. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
7. King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of Altace with Hydrochlorothiazide
8. Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for Psychotic Major Depression Misses Primary Endpoint
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Post Your Comments:
(Date:10/13/2008)...of Genomic DNA from Multiple Cancer Populations Fa...es, ANN ARBOR, Mich., Oct. 13 /- Rub...ith SAIC-Frederick to amplify DNA samples for The,...s selected to amplify and standardize total genomi...cer patients. The Rubicon,GenomePlex(TM) Whole Gen...
(Date:10/10/2008)...N and MENLO PARK, Calif., Oct. 10 /PRNewswire-Firs...nced that it plans to present,long-term follow-up ... next,week at the Cardiovascular Research Foundati...scular Therapeutics (TCT) meeting in Washington, D...ies designed to investigate,the safety and efficac...
(Date:10/10/2008)...N, Calif., Oct. 10 /- TriReme Medical...rized to affix the CE (Conformite,Europeenne) mark...ronary,Stent System, a unique main vessel stent sy...y bifurcations., Representing the next generation...as potential use in a quarter of the 2.2 million,a...
(Date:10/9/2008)...ranslational Science Institute, Navigenics, Affyme...tudy, SAN DIEGO, Oct. 9 /- A consort...s have joined forces in a first-of-its-kind,resear...al genetic testing,on people who choose to receive...for developing certain diseases., Sponsored by Sc...
Breaking Medicine Technology:Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 2Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 3USC receives nearly 2427 million in funding for new stem cell research facility 18716 1USC receives nearly 2427 million in funding for new stem cell research facility 18716 2The FAQs about the human genome 3230 1AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence 18713 1AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence 18713 2
...ESS WIRE)--Jun 21, 2007 - Answerthink, Inc. (NASDA...tegic alliance with,LORENZ Life Sciences Group for...rica. Answerthink and LORENZ Life Sciences Group w...actice submissions,management solutions into Answe...ology., Answerthink,s pre-configured EzLifeScience...
...June 20, 2007 /PRNewswire-USNewswire/ -- The,follo...on stem cell,veto and executive order: , East Room...d you,re here. America is a,nation that leads the ...irit is making possible incredible advances in,med...rica is also a,nation founded on the principle tha...
Other Medicine Technology:Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 2Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 3Remarks by President Bush on Stem Cell Veto and Executive Order 2Remarks by President Bush on Stem Cell Veto and Executive Order 3Remarks by President Bush on Stem Cell Veto and Executive Order 4Remarks by President Bush on Stem Cell Veto and Executive Order 5Remarks by President Bush on Stem Cell Veto and Executive Order 6
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...earchers from Australia have come to the conclusio...s for Alzheimer's disease, does not add changes in... and memory during most of their adulthood. Those ...cted by dementia, only much later in old age, alon...
...scientists find, sleep pattern controls mental hea... insomnia //and hypersomnia are severely depressed...Sleep-disturbed children, with both insomnia and h... to face severe depression than those with either ...
...ording to Suzanna Zick, a naturopathic physician a... System , adding spices such //as basil, oregano, ...fit health. "Adding herbs and spices can help you... can help prevent certain cancers, and even lower ...
...imia has always been considered to have a psycholo...es, may be the cause. //The findings suggests that...on could be treated with the contraceptive pill. ...nduces sufferers to eat too much of food and then ...
Other Medicine News:Health News:Carriers With Alzheimer's High Risk Gene Type Age Normally Until the Disease Strikes 2Health News:Bulimia Can Be Treated With Contraceptive Pills 2
Ideal for biocompatibility testing at various temperatures, this chamber provides continuous circulation of air through a clean heating unit to maintain a constant internal temperature up to 140F. Tr
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors
This fume hood is the same as model Scienceware H50000-0003, but includes a flat internal baffle across the rear of the shell. The baffle slopes forward, leaving space beneath for air flow to sweep t
... is an economical unit designed for small faciliti...s are needed. Excellent for use in schools, junior...-piece shell molded of chemical resistant polyethy.... A clear acrylic panel slides on a track featurin...
Medicine Products: